Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $20.37 USD
Change Today +0.15 / 0.74%
Volume 519.3K
MNTA On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Craig A. Wheeler

Chief Executive Officer, President and Executive Director,Momenta Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 76 board members in 3 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Craig A. Wheeler has been the Chief Executive Officer and President of Momenta Pharmaceuticals Inc. since September 12, 2006 and August 22, 2006 respectively. Mr. Wheeler serves as the Board Chairman, Treasurer and Secretary of Generic Pharmaceutical Association. He has extensive professional experience in the biotechnology and healthcare industries. Mr. Wheeler served as a Vice President of Chiron Corp. from August 2001 to June 2006. He served as the President of ...

Read Full Background

Corporate Headquarters*

675 West Kendall Street
Cambridge, Massachusetts 02142

United States

Phone: 617-491-9700
Fax: 617-621-0431

Board Members Memberships*

Board Chairman, Treasurer and Secretary
Chief Executive Officer, President and Executive Director


Cornell University
Cornell University
University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$643,356

Stock Options*

Restricted Stock Awards$1,257,200
All Other Compensation$29,610
Exercisable Options940,750
Exercisable Options Value$517,510
Unexercisable Options251,250
Total Value of Options$517,510
Total Number of Options1,192,000

Total Compensation*

Total Annual Cash Compensation$1,105,301
Total Short Term Compensation$643,356
Other Long Term Compensation$1,286,810
Total Calculated Compensation$3,921,065
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MNTA:US $20.37 USD +0.15


Friedhelm Blobel Ph.D.Chief Executive Officer, President, Executive Director and Member of Business Development Committee
SciClone Pharmaceuticals, Inc.
Rajesh C. Shrotriya M.D.Chairman and Chief Executive Officer
Spectrum Pharmaceuticals, Inc.
John F. Thero Chief Executive Officer, President, Assistant Secretary and Director
Amarin Corporation plc
Douglas A. Michels Chief Executive Officer, President and Director
OraSure Technologies, Inc.
Peter S. Greenleaf Chief Executive Officer and Director
Sucampo Pharmaceuticals, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MOMENTA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at